Latest Asx News

Eureka Group Holdings has acquired Barrier Reef Tourist Park in Cairns for $3.5 million, targeting strong rental yields and development upside amid regional growth.

Way2VAT Ltd has successfully raised A$2 million through a discounted share placement, aiming to bolster working capital and reduce short-term debt as it capitalises on recent client wins.

Clean TeQ Water reports a successful lithium extraction pilot and the amicable termination of its LithiumBank agreements, setting the stage for new global deployments of its cDLE® technology.

G11 Resources has appointed Martin Donohue as Executive Chairman to fast-track exploration at its Wilandra VMS Copper project while its CEO steps down, signaling a strategic pivot.

National Australia Bank has updated key details on its 2025 interim dividend, including dividend reinvestment and bonus security plans, setting clear terms for shareholders ahead of the July payment.

Golden Horse Minerals has successfully raised A$15 million to accelerate exploration at its Southern Cross Gold Project, with plans to expand drilling activities and pursue a potential copper acquisition.

Neurotech International has reported positive human pharmacokinetic results for NTI164, a cannabinoid formulation designed for paediatric neurological disorders, confirming rapid absorption and a non-intoxicating profile.

EV Resources Limited has agreed to sell its Yanamina Gold and Silver Project in Peru to Daura Gold Corp for US$6 million, a move that will bolster EVR’s cash reserves and sharpen its strategic focus.

BSA Limited announces a significant leadership overhaul and financial restructuring following a failed NBN Co tender, appointing Sasho Kacevski as CEO and Arjan van Ameyde as CFO to steer the company’s next phase.

Radiopharm Theranostics has unveiled encouraging preclinical results for its Lu177-B7H3 monoclonal antibody, RV01, paving the way for a mid-2025 Investigational New Drug submission and a Phase 1 trial later that year.

Redivium Limited has secured a definitive five-year marketing and offtake agreement with WMC Energy BV, ensuring exclusive global sales of black mass from its UK battery recycling facility.

Lumos Diagnostics has reached 50% recruitment of bacterial positive patients in its pivotal FebriDx CLIA waiver clinical study, setting the stage for a planned FDA submission in late 2025 and unlocking a substantial US market opportunity.